Compound Detail
CHEMBL4174263
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4174263 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CCKGDXBVZQSGGC-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
503.6
MW (Da)
5.45
ALogP
7
HBA
1
HBD
109.2
PSA (Ų)
0.34
QED
2
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.06
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Nuclear receptor ROR-gamma CHEMBL1741186 | IC50 | 7.06 | 6.89 | 88.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Nuclear receptor ROR-gamma | IC50 | = | 88.0 | nM | 7.06 | Displacement of [3H]-2-(4-(ethylsulfonyl)phenyl)-N-(4-(2-(methoxymethyl)phenyl)t... | 30095900 |
| Nuclear receptor ROR-gamma | IC50 | = | 190.0 | nM | 6.72 | Inverse agonist activity at RORgammat in human TH17 cells assessed as inhibition... | 30095900 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30095900 | 10.1021/acs.jmedchem.8b00783 | Nuclear receptor ROR-gamma | 4 |
| 30095900 | 10.1021/acs.jmedchem.8b00783 | No relevant target | 1 |
| 30095900 | 10.1021/acs.jmedchem.8b00783 | Unchecked | 1 |
| 30095900 | 10.1021/acs.jmedchem.8b00783 | Hepatocyte | 1 |
Data from ChEMBL 36 via Core Engine